Facial Vascularized Composite Allotransplantation

1

Review clinical trials related to Facial Vascularized Composite Allotransplantation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Facial Vascularized Composite Allotransplantation: A Study Evaluating Safety, Functional Outcomes, and Patient-Reported Psychosocial Outcomes

The primary objective of this study is to evaluate the 5-year (60-month) allograft survival rate of facial vascularized composite allotransplantation performed under the standardized CONSORT clinical protocol.

Participants needed: 5
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Yale UniversityUpdated: Sep 9, 2026Locations: 9
Eligibility criteria

Competent to provide informed consent, as determined through structured clinical... [+26]

Anatomical or surgical factors that render transplantation unsafe or technically... [+25]